A Double-Blind Randomized Placebo-Controlled Withdrawal Trial Comparing Memantine and Antipsychotics for the Long-Term Treatment of Function and Neuropsychiatric Symptoms in People With Alzheimer's Disease (MAIN-AD).

BACKGROUND: Neuropsychiatric symptoms in Alzheimer disease (AD) cause significant distress and present a complex clinical challenge for treatment. Pharmacological treatment options are limited to antipsychotics, which carry extensive safety issues. There is emerging evidence to support the potential...

Full description

Bibliographic Details
Main Authors: Ballard, C, Thomas, A, Gerry, S, Yu, L, Aarsland, D, Merritt, C, Corbett, A, Davison, C, Sharma, N, Khan, Z, Creese, B, Loughlin, P, Bannister, C, Burns, A, Win, SN, Walker, Z
Format: Journal article
Language:English
Published: Elsevier 2015